Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - CASH & EQUIVALENTS
Cash & Equivalents ABUS - Arbutus Biopharma Corporation
26.3 M
LAST VALUE
-50.96%
2 YEAR CAGR
-6.56%
5 YEAR CAGR
-9.16%
10 YEAR CAGR